Structural and gene expression abnormalities induced by retinoic acid in the forebrain

Reproductive Toxicology

Volumn 12, Issue 2, 1998, Pages 169-176

  Clotman, Frederic ^a   Van Maele Fabry, Genevieve ^a   Chu Wu, Liu ^a,c   Picard, Jacques J ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Laboratory of Developmental Genetics   (Belgium)

^c GUANGDONG OCEAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; NERVE PROTEIN; OTX2 PROTEIN; RETINOIC ACID; TRANSACTIVATOR PROTEIN;

ADULT; ANIMAL; ANIMAL EXPERIMENT; BIOSYNTHESIS; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CHILD; CONFERENCE PAPER; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DRUG EFFECT; EMBRYO; FOREBRAIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MORPHOGENESIS; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOLOGY; PRENATAL EXPOSURE; STRUCTURAL GENE; TERATOGENICITY;

ANIMALIA;

EID: 0032034167     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00151-2     Document Type: Conference Paper

References (56)

1. 1. Means AL, Gudas LJ. The roles of retinoids in vertebrate development. Annu Rev Biochem. 1995;64:201-33.
2. 2. Soprano DR, Soprano KJ. Retinoids as teratogens. Annu Rev Nutr. 1995;15:111-32.
3. 3. Boyd AS. An overview of the retinoids. Am J Med. 1989;86:558-73.
4. 4. Goldfarb MT, Ellis CN, Voorhees JJ. Retinoids in dermatology. Mayo Clin Proc. 1987;62:1161-4.
5. 5. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embropathy. N Engl J Med. 1985;313:837-41.
6. 6. Lammer EJ, Hayes AM, Schunior A, Holmes LB. Unusually high adverse outcomes of pregnancy following isotretinoin exposure. Am J Hum Genet. 1987;43:A58.
7. 7. Lammer EJ, Armstrong DL. Malformations of hindbrain structures among humans exposed to isotretinoin (13-cis-retinoic acid) during early embryogenesis. In: Morriss-Kay G, ed. Retinoids in normal development and teratogenesis. Oxford: Oxford University Press; 1992:281-95.
8. 8. Rosa FW, Wilk AL, Kelsey FO. Teratogen update: vitamin A congeners. Teratology. 1986;33:355-64.
9. 9. Maden M, Holder N. Retinoic acid and development of the central nervous system. Bioessays. 1992;14:431-8.
10. 10. Creech Kraft J, Kochhar DM, Scott WJ, Nau H. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryonic concentrations during embryogenesis: comparison to the all-trans isomer. Toxicol Appl Pharmacol. 1987;87:474-82.
11. 11. Creech Kraft J, Nau H, Lammer E, Olney A. Embryonic retinoid concentrations after maternal intake of isotretinoin. N Engl J Med. 1989;321:262-3.
12. 12. Creech Kraft J, Löfberg B, Chahoud I, Bochert G, Nau H. Teratogenicity and placental transfer of all-trans-, 13-cis-. 4-Oxo-all-trans-, and 4-Oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicol Appl Pharmacol. 1989;100:162-76.
13. 13. Creech Kraft J, Slikker W Jr, Bailey JR, et al. Plasma pharmacokinetics and metabolism of 13-cis-and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis-and all-trans-retinyl-β-glucuronides. Drug Metab Dispos. 1991;19:317-24.
14. 14. Creech Kraft J. Pharmacokinetics, placental transfer, and teratogenicity of 13-cis-retinoic acid, its isomer and metabolites. In: Morriss-Kay G. ed. Retinoids in normal development and teratogenesis. Oxford: Oxford University Press; 1992:267-80.
15. 15. Adams J. Structure-activity and dose-response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol. 1993;15:193-202.
16. 16. Katsuyama Y, Wada S, Yasugi S, Saiga H. Expression of the labial group Hox gene HrHox-1 and its alteration induced by retinoic acid in development of the ascidian Halocynthia roretzi. Development. 1995;121:3197-205.
17. 17. Holland LZ, Holland ND. Expression of AmphiHox-1 and AmphiPax-1 in amphioxus embryos treated with retinoic acid: insights into evolution and patterning of the chordate nerve cord and pharynx. Development. 1996;122:1829-38.
18. 18. Gammill LS, Sive H. Identification of otx2 target genes and restrictions in ectodermal competence during Xenopus cement gland formation. Development. 1997;124:471-81.
19. 19. Durston AJ, Timmermans JPM, Hage WJ, et al. Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature (London). 1989;340:140-4.
20. 20. Pannese M, Polo C, Andreazzoli M, et al. The Xenopus homolog of Otx2 is a maternal homeobox gene that demarcates and specifies anterior body regions. Development. 1995;121:707-20.
21. 21. Chen Y, Solursh M. Comparison of Hensen's node and retinoic acid in secondary axis induction in the early chick embryo. Dev Dyn. 1992;195:142-51.
22. 22. Drysdale TA, Crawford MJ. Effects of localized application of retinoic acid on Xenopus laevis development. Dev Biol. 1994;162: 394-401.
23. 23. Sulik KK, Cook CS, Webster WS. Teratogens and craniofacial malformations: relationships to cell death. Development. 1988;103 (Suppl.):213-32.
24. 24. Alles AJ, Sulik KK. Retinoic-acid-induced limb reduction defects: perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology. 1989;40:163-71.
25. 25. Alles AJ, Sulik KK. Retinoic acid-induced spina bifida: evidence for a pathogenetic mechanism. Development. 1990;108:73-81.
26. 26. Abbott BD, Hill LG, Birnbaum LS. Processes involved in retinoic acid production of small embryonic palatal shelves and limb defects. Teratology. 1990;41:299-310.
27. 27. Watanabe T, Willis WD, Goulding EH, Pratt RM. Effects of isotretinoin in vitro on mouse facial development. Teratology. 1986;33:73C.
28. 28. Tamarin A, Crawley A, Lee J, Tickle C. Analysis of upper beak defects in chicken embryos following retinoic acid treatment. J Embryol Exp Morphol. 1984;84:105.
29. 29. Hassell JR, Greenberg JH, Johnston MC. Inhibition of cranial neural crest cell development by vitamin A in the cultured chick embryo. J Embryol Exp Morphol. 1977;39:267-71.
30. 30. Wiley MJ, Cauwenbergs P, Taylor IM. Effects of retinoic acid on the development of the facial skeleton in hamsters: early changes involving cranial neural crest cells. Acta Anat. 1983;116:180-92.
31. 31. Webster WS, Johnston MC, Lammer EJ, Sulik KK. Isotretinoin embryopathy and the cranial neural crest: an in vivo and in vitro study. J Cran Genet Dev Biol. 1986;6:211-22.
32. 32. Ito K, Morita T. Role of retinoic acid in mouse neural crest cell development in vitro. Dev Dyn. 1995;204:211-8.
33. 33. Thorogood P, Smith L, Nicol A, McGinty R, Garrod D. Effects of vitamin A on the behaviour of migratory neural crest cells in vitro. J Cell Sci. 1982;57:331-50.
34. 34. Pratt RM, Goulding EH, Abbott BD. Retinoic acid inhibits migration of cranial neural crest cells in the cultured mouse embryo. J Cran Genet Dev Biol. 1987;7:205-17.
35. 35. Moro Balbas JA, Gato A, Alonso Revuelta MI, Pastor JF, Represa JJ, Barboda E. Retinoic acid induces changes in the rhombencephalic neural crest cells migration and extracellular matrix composition in the chick embryos. Teratology. 1993;48:197-206.
36. 36. Morriss-Kay G, Mahmood R. Morphogenesis-related changes in extracellular matrix induced by retinoic acid. In: Morriss-Kay G, ed. Retinoids in normal development and teratogenesis. Oxford: Oxford University Press; 1992:165-80.
37. 37. Simeone A, Acampora D, Mallamaci A, et al. A vertebrate gene related to orthodenticle contains a homeodomain of the bicoid class and demarcates anterior neuroectoderm in the gastrulating mouse embryo. EMBO J. 1993;12:2734-47.
38. 38. Ang S-L, Jin O, Rhinn M, Daigle N, Stevenson L, Rossant J. A targeted mouse Otx2 mutation leads to severe defects in gastrulation and formation of axial mesoderm and to deletion of rostral brain. Development. 1996;122:243-52.
39. -/ - mutants due to a defective anterior neuroectoderm specification during gastrulation. Development. 1995;121:3279-90.
40. 40. Matsuo I, Kuratani S, Kimura C, Takeda N, Aizawa S. Mouse Otx2 functions in the formation and patterning of rostral head. Gene Dev. 1995;9:2646-58.
41. 41. Simeone A, Avantaggiato V, Moroni MC, et al. Retinoic acid induces stage-specific antero-posterior transformation of rostral central nervous system. Mech Dev. 1995;51:83-98.
42. 42. Bally-Cuif L, Gulisano M, Broccoli V, Boncinelli E. c-otx2 is expressed in two different phases of gastrulation and is sensitive to retinoic acid treatment in chick embryo. Mech Dev. 1995;49:49-63.
43. 43. Ang S-L, Conlon RA, Jin O, Rossant J. Positive and negative signals from mesoderm regulate the expression of mouse Otx2 in ectoderm explants. Development. 1994;120:2979-89.
44. 44. Avantaggiato V, Acampora D, Tuorto F, Simeone A. Retinoic acid induces stage-specific repatterning of the rostral central nervous system. Dev Biol. 1996;175:347-57.
45. 45. Tabin CJ. Retinoids, homeoboxes, ans growth factors: toward molecular models for limb development. Cell. 1991;66:199-217.
46. 46. Mavilio F. Regulation of vertebrate homeobox-containing genes by morphogens. Eur J Biochem. 1993;212:273-88.
47. 47. Kessel M. Reversal of axonal pathways from rhombomere 3 correlates with extra Hox expression domains. Neuron. 1993;10: 379-93.
48. 48. Conlon RA, Rossant J. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development. 1992;116:357-68.
49. 49. Marshall H, Nonchev S, Sham MH, Muchamore I, Lumsden A, Krumlauf R. Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity. Nature (London). 1992;360:737-41.
50. 50. Morriss-Kay GM, Murphy P, Hill RE, Davidson DR. Effects of retinoic acid excess on expression of Hox-2.9 and Krox-20 and on morphological segmentation in the hindbrain of mouse embryos. EMBO J. 1991;10:2985-95.
51. 51. Wood H, Pall G, Morriss-Kay G. Exposure to retinoic acid before and after the onset of somitogenesis reveals separate effects on rhombomeric segmentation and 3′ HoxB gene expression domains. Development. 1994;120:2279-85.
52. 52. Clotman F, Van Maele-Fabry G, Picard JJ. Retinoic acid induces a tissue-specific deletion in the expression domain of Otx2. Neurotoxicol Teratol. 1997;19:1-7.
53. 53. Sulik KK, Dehart DB, Rogers JM, Chernoff N. Teratogenicity of low doses of all-trans retinoic acid in presomite mouse embryos. Teratology. 1995;51:398-403.
54. 54. Wagner M, Han B, Jessell TM. Regional differences in retinoid release from embryonic neural tissue detected by an in vitro reporter assay. Development. 1992;116:55-66.
55. 55. Chen Y, Huang L, Solursh M. A concentration gradient of retinoids in the early Xenopus laevis embryo. Dev Biol. 1994;161: 70-6.
56. 56. Horton C, Maden M. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev Dyn. 1995;202:312-23.-